SLC6A4 and Diarrhea: Interestingly, bosutinib, which has the highest incidence of diarrhoea amongst the TKIs, inhibits SERT by 71% as an off-target effect22 suggesting bosutinib-induced diarrhoea may occur through elevated circulating 5-HT levels.